1)Treatment of Age-Related Macular Degeneration with Photodynamic Therapy(TAP)Study Group:Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:two-year results of 2 randomized clinical trials. TAP report 2. Arch Ophthalmol 119:198-207, 2001
2)Treatment of Age-Related Macular Degeneration with Photodynamic Therapy(TAP)and Verteporfin in Photodynamic Therapy(VIP)Study Group:Acute severe visual acuity decrease after photodynamic therapy with verteporfin:case reports from randomized clinical trials. TAP and VIP report No. 3. Am J Ophthalmol 137:683-696, 2004
3)Axer-Siegel R, Ehrlich R, Rosenblatt I et al:Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 122:453-459, 2004
4)Mitchell J, Johnson RN, McDonald HR et al:Intravitreal bevacizumab for previously treated choroidal neovasculalization from age-related macular degeneration. Retina 27:432-438, 2007
5)Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C et al:Influence of photodynamic therapy on expression of vascular endothelial growth factor(VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4473-4480, 2003
6)Gass JDM:Pathogenesis of disciform detachment of the neuroepitherium. Ⅲ. Senile disciform macular degeneration. Am J Ophthalmol 63:617-644, 1967
7)Bird AC, Marshall J:Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc UK 105:674-682, 1986
8)Poliner LS, Olk RJ, Burgess D et al:Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 93:543-551, 1986
9)Lim JI, Aaberg TM, Capone A Jr et al:Indocyanine green angiography-guided photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment. Am J Ophthalmol 123:524-532, 1997